A team of scientists has uncovered the remarkable potential of a human antibody, mAb 3A6, in fighting Ebola virus infections.

An investigational monoclonal antibody called bentracimab can safely and effectively reverse potentially catastrophic bleeding complications linked to ticagrelor, a common drug used to treat patients ...

The U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) and medical research charity Lifearc have announced a collaboration to develop an affordable and accessible monoclonal ...

Akeso, Inc. (9926.HK) ('Akeso' or the 'Company') is excited to announce that the U.S. Food and Drug Administration (FDA) has approved its differentiated PD-1 monoclonal antibody, penpulimab-kcqx, in ...

Representative Vern Buchanan (R-FL) issued a statement praising the Food and Drug Administration's (FDA) recent decision to ...

HONG KONG, April 18, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) (“Akeso” or the “Company”) is pleased to announce that ebdarokimab, an investigational monoclonal antibody developed by the company, has ...

Foralumab is the first fully human anti-CD3 monoclonal antibody administered via the intranasal route. This novel, non-systemic approach is designed to engage regulatory T cells, promoting immune ...

Sanofi and Regeneron's Dupixent (dupilumab) has gained approval from the FDA for chronic spontaneous urticaria (CSU) ...

Did you know that April 22 was National Parvo Awareness Day? Considering this was the second year that it was celebrated, you ...

Antibodies that interfere with IL-6 function Tocilizumab is a monoclonal antibody directed against the IL-6 receptor that has established benefit in RA both with regards to clinical efficacy and ...